Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.
We reviewed clinical and billing data from a university-based health system to assess HPV vaccine utilization among 9-18-year-old girls by individual, visit and medical specialty characteristics. Our sample included 10,082 adolescent patients with 27,928 visits to outpatient family medicine (FM), pediatric and gynecology clinics between January 2007 and March 2008. Vaccine series completion was low among eligible adolescents (15%), with important disparities in vaccine utilization by medical specialty, age, race and insurance status. Missed opportunities for vaccination were common. Our findings may help to target future interventions aimed at increasing adolescent HPV vaccine utilization.
Dempsey
Amanda
A
University of Michigan, Department of Pediatrics, Child Health Evaluation and Research Unit, Ann Arbor, MI 48109-5456, USA. adempsey@umich.edu
Cohn
Lisa
L
Dalton
Vanessa
V
Ruffin
Mack
M
D000293:Adolescent; D000367:Age Factors; D002648:Child; D005260:Female; D006801:Humans; D008511:Medicine; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D044469:Racial Groups; D012959:Socioeconomic Factors; D014481:United States; D014495:Universities; D014611:Vaccination / Q000706:statistics & numerical data*
D053918:Papillomavirus Vaccines